Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at NOK 838.5B, ahead of Johnson & Johnson (NOK 790.7B) and Sanofi (NOK 767.9B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerNOK 838.5B
- Median
- NOK 8.5B
- Combined market value
- NOK 49.89T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | NOK 838.5B | NOK 1.57T | NOK 276.01 | 0.02% up | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | NOK 790.7B | NOK 6.5T | NOK 2,699.32 | 0.16% down | 38% up | ||
| 3 | SanofiSNY · Health Care | NOK 767.9B | NOK 1.11T | NOK 461.07 | 0.04% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | NOK 510.1B | NOK 3.36T | NOK 1,363.43 | 1.95% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | NOK 505.5B | NOK 1.76T | NOK 1,015.28 | 0.05% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | NOK 471.9B | NOK 2.72T | NOK 1,753.86 | 0.74% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | NOK 451.2B | NOK 666.8B | NOK 208.72 | 0.55% down | 54% up | ||
| 8 | NovartisNVS · Health Care | NOK 447.3B | NOK 2.89T | NOK 1,527.79 | 1.01% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | NOK 303.1B | NOK 967.8B | NOK 9,355.89 | 0.74% up | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | NOK 279.2B | NOK 1.72T | NOK 391.30 | 0.86% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | NOK 257.3B | NOK 12.24T | NOK 13,738.24 | 0.10% up | 35% up | ||
| 12 | GSKGSK · Health Care | NOK 210.8B | NOK 956.7B | NOK 477.26 | 0.01% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | NOK 181B | NOK 1.32T | NOK 5,191.52 | 0.22% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | NOK 179.1B | NOK 1.21T | NOK 590.81 | 0.73% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | NOK 142.6B | NOK 228.9B | NOK 199.70 | 0.71% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | NOK 94.2B | NOK 383.8B | NOK 667.51 | 0.23% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 76.7B | NOK 484.3B | NOK 415.10 | 0.47% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | NOK 68.8B | NOK 241.3B | NOK 5,665.25 | 0.03% up | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | NOK 63.5B | NOK 128B | NOK 256.09 | 2.17% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | NOK 59B | NOK 110.8B | NOK 571.90 | 0.80% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | NOK 56.7B | NOK 57B | NOK 83.68 | 0.00% | 1% up | ||
| 22 | GenmabGMAB · Health Care | NOK 56.7B | NOK 310.5B | NOK 503.54 | 0.06% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | NOK 43.9B | NOK 273B | NOK 376.78 | 0.38% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | NOK 42.3B | NOK 453.7B | NOK 3,972.28 | 0.87% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 41.9B | NOK 149.6B | NOK 2,329.93 | 0.18% down | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 38.9B | NOK 120.8B | NOK 144.87 | 0.95% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | NOK 32.3B | NOK 331.2B | NOK 815.19 | 0.71% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | NOK 17.6B | NOK 75.3B | NOK 447.93 | 1.64% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | NOK 9.9B | NOK 57.7B | NOK 2,882.49 | 1.18% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | NOK 9.7B | NOK 31.6B | NOK 162.80 | 4.22% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | NOK 8.5B | NOK 82.7B | NOK 2,959.67 | 0.06% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | NOK 7.7B | NOK 203.1B | NOK 1,516.63 | 0.06% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | NOK 7.5B | NOK 62.1B | NOK 1,529.34 | 0.00% | 31% up | ||
| 34 | InsmedINSM · Health Care | NOK 7.2B | NOK 259.7B | NOK 1,183.75 | 0.18% up | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | NOK 6.9B | NOK 87.4B | NOK 920.15 | 1.16% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | NOK 6.4B | NOK 81.9B | NOK 102.35 | 1.08% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | NOK 6.3B | NOK 93B | NOK 615.48 | 1.22% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | NOK 6.3B | NOK 75B | NOK 685.11 | 0.83% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | NOK 6.2B | NOK 47.7B | NOK 274.31 | 1.58% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | NOK 6B | NOK 79.7B | NOK 1,221.28 | 1.03% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 5.8B | NOK 94.7B | NOK 4,077.20 | 0.36% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 5.5B | NOK 73.4B | NOK 934.22 | 1.30% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.1B | NOK 44.8B | NOK 409.53 | 0.46% up | 88% up | ||
| 44 | ABIVAXABVX · Health Care | NOK 4.9B | NOK 70.6B | NOK 806.36 | 1.29% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | NOK 4.8B | NOK 47.7B | NOK 846.41 | 0.36% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | NOK 4.7B | NOK 44.4B | NOK 266.65 | 2.00% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | NOK 4.6B | NOK 64.9B | NOK 957.48 | 2.52% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 4.5B | NOK 59.1B | NOK 417.77 | 0.22% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | NOK 3.2B | NOK 39.1B | NOK 285.76 | 0.31% up | 169% up | ||
| 50 | ErascaERAS · Health Care | NOK 3.2B | NOK 47B | NOK 133.91 | 0.58% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | NOK 3.1B | NOK 57.9B | NOK 887.52 | 0.46% down | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 1.3B | NOK 77.9B | NOK 1,123.92 | 0.60% down | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | NOK 1.1B | NOK 47.5B | NOK 494.33 | 0.23% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | NOK 856.2M | NOK 69.7B | NOK 1,324.74 | 0.49% up | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -NOK 686.5M | NOK 72.3B | NOK 207.57 | 1.36% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -NOK 1.2B | NOK 51.7B | NOK 1,226.27 | 0.46% up | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -NOK 1.8B | NOK 172.4B | NOK 2,628.15 | 0.06% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -NOK 2B | NOK 48.8B | NOK 583.97 | 0.22% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -NOK 6.4B | NOK 70.3B | NOK 504.75 | 0.78% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -NOK 20.2B | NOK 145.5B | NOK 746.83 | 0.29% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -NOK 31.7B | NOK 5T | NOK 2,827.80 | 0.42% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6965 NOK).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (NOK 838.5B), Johnson & Johnson (NOK 790.7B) and Sanofi (NOK 767.9B) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of NOK 49.89T as of 18 Nov 2026, 14:39 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.